Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US

di Bharmal, Murtuza, Kearney, Mairead, Zheng, Ying, Phatak, Hemant
Pubblicato in Clinicoecon Outcomes Res (2019)

Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials

di Bharmal Murtuza, Bhanegaonkar Abhijeet, Canafax Daniel M, Calloway Michael
Pubblicazione 2011-04-01

Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials

di Canafax, Daniel M, Bhanegaonkar, Abhijeet, Bharmal, Murtuza, Calloway, Michael
Pubblicazione 2011

What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches

di Hatswell, Anthony J., Bullement, Ash, Schlichting, Michael, Bharmal, Murtuza
Pubblicato in Appl Health Econ Health Policy (2020)

Trends in CNS Prescribing Following the Economic Slowdown

di Cascade, Elisa, Kalali, Amir H., Kwentus, Joseph A., Bharmal, Murtuza
Pubblicazione 2009

Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with...

di Bharmal, Murtuza, Nolte, Sandra, Henry-Szatkowski, Mickaël, Hennessy, Meliessa, Schlichting, Michael
Pubblicato in Health Qual Life Outcomes (2020)

Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection

di Bullement, Ash, Willis, Anna, Amin, Amerah, Schlichting, Michael, Hatswell, Anthony James, Bharmal, Murtuza
Pubblicato in BMC Med Res Methodol (2020)

How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical t...

di Bharmal, Murtuza, Guillemin, Isabelle, Marrel, Alexia, Arnould, Benoit, Lambert, Jérémy, Hennessy, Meliessa, Fofana, Fatoumata
Pubblicato in Orphanet J Rare Dis (2018)

Living with Merkel Cell Carcinoma (MCC): Development of a Conceptual Model of MCC Based on Patient Experiences

di Kaufman, Howard L., Dias Barbosa, Carla, Guillemin, Isabelle, Lambert, Jérémy, Mahnke, Lisa, Bharmal, Murtuza
Pubblicato in Patient (2018)

Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma

di Nghiem, Paul, Kaufman, Howard L, Bharmal, Murtuza, Mahnke, Lisa, Phatak, Hemant, Becker, Jürgen C
Pubblicato in Future Oncol (2017)

Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

di Lanitis, Tereza, Proskorovsky, Irina, Ambavane, Apoorva, Hunger, Matthias, Zheng, Ying, Bharmal, Murtuza, Phatak, Hemant
Pubblicato in Adv Ther (2019)

Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives

di Kongnakorn, Thitima, Bharmal, Murtuza, Kearney, Mairead, Phatak, Hemant, Benedict, Agnes, Bhanegaonkar, Abhijeet, Galsky, Matthew
Pubblicato in Clinicoecon Outcomes Res (2019)

Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications

di Bharmal, Murtuza, Payne, Krista, Atkinson, Mark J, Desrosiers, Marie-Pierre, Morisky, Donald E, Gemmen, Eric
Pubblicazione 2009

Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma

di Bharmal, Murtuza, Fofana, Fatoumata, Barbosa, Carla Dias, Williams, Paul, Mahnke, Lisa, Marrel, Alexia, Schlichting, Michael
Pubblicato in Health Qual Life Outcomes (2017)

Correction to: Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma

di Bharmal, Murtuza, Fofana, Fatoumata, Barbosa, Carla Dias, Williams, Paul, Mahnke, Lisa, Marrel, Alexia, Schlichting, Michael
Pubblicato in Health Qual Life Outcomes (2019)

Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma

di Bullement, Ash, Nathan, Paul, Willis, Anna, Amin, Amerah, Lilley, Cameron, Stapelkamp, Ceilidh, Hatswell, Anthony, Pescott, Chris, Bharmal, Murtuza
Pubblicato in Pharmacoecon Open (2019)

Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment...

di Doshi, Gurjyot K, Bhanegaonkar, Abhijeet, Kearney, Mairead, Bharmal, Murtuza, Cislo, Paul, Kim, Ruth, Boyd, Marley, Aguilar, Kathleen M, Phatak, Hemant
Pubblicato in Clinicoecon Outcomes Res (2020)

Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinica...

di Lambert, Jérémy, Marrel, Alexia, D’Angelo, Sandra P., Burgess, Melissa A., Chmielowski, Bartosz, Fazio, Nicola, Gambichler, Thilo, Grob, Jean-Jacques, Lebbé, Céleste, Robert, Caroline, Russell, Jeffrey, Güzel, Gülseren, Bharmal, Murtuza
Pubblicato in Patient (2020)

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe

di Becker, Jürgen C., Lorenz, Eva, Ugurel, Selma, Eigentler, Thomas K., Kiecker, Felix, Pföhler, Claudia, Kellner, Ivonne, Meier, Friedegund, Kähler, Katharina, Mohr, Peter, Berking, Carola, Haas, Gabriele, Helwig, Christoph, Oksen, Dina, Schadendorf, Dirk, Mahnke, Lisa, Bharmal, Murtuza
Pubblicato in Oncotarget (2017)

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma

di D’Angelo, Sandra P., Hunger, Matthias, Brohl, Andrew S., Nghiem, Paul, Bhatia, Shailender, Hamid, Omid, Mehnert, Janice M., Terheyden, Patrick, Shih, Kent C., Brownell, Isaac, Lebbé, Céleste, Lewis, Karl D., Linette, Gerald P., Milella, Michele, Schlichting, Michael, Hennessy, Meliessa H., Bharmal, Murtuza
Pubblicato in Cancer Immunol Immunother (2019)